ChaoNJ et al. A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.Blood1994: 83: 2823–2828.
2.
CascinuS et al. Recombinant human erythropoietin in cis-platin associated anemia: a randomized double-blind trial with placebo.J Clin Oncol1994; 12:1058–1062.
3.
Del MastroL et al. Erythropoietin in the prevention of chemotherapy induced anemia: results from a randomized trial in early breast cancer patients. Proc Am Soc Clin Oncol1995; 14: 256.
4.
GamucciMT et al. Antianemic activity of erythropoietin in cisplatin-treated patients: a randomized trial. Proc Am Soc Clin Oncol1992; 11: 1431.
5.
LinkH et al. A controlled trial of recombinant human erythropoietin after bone marrow transplantation. Blood1994; 84: 3327–3335
6.
MarkmanM et al. The use of recombinant human erythropoietin to prevent carboplatin-induced anemia. Gynecol Oncol1993; 49: 172–176.
7.
MarmontAM.Eritropoietina: profilo biochimico, ricordi biologici, indicazioni e risultati terapeutici in ematologia. Tumori, 83 (Suppl 2);4:S3–S15.
